“…Our model, the first discrete support-vector machine, offers distinct features (e.g., the ability to classify any number of groups, management of the curse of dimensionality in data attributes, and a reserved-judgment region to facilitate multi-stage classification analysis) that are not simultaneously available in existing classification software. 32,33,49,50,56 Studies involving tumor volume identification, ultrasonic cell disruption in drug delivery, lung tumor cell motility analysis, CpG island aberrant methylation in human cancer, predicting early atherosclerosis using biomarkers, and fingerprinting native and angiogenic microvascular networks using functional perfusion data indicate that our zapproach is adaptable and can produce effective and reliable predictive rules for various biomedical and bio-behavior phenomena. 13,25,26,51,53,55,57 , Section ''Background'' briefly describes the background of discriminant analysis.…”